Medicine Studies

, Volume 2, Issue 2, pp 121–137 | Cite as




  1. Adlin, V. 1998. Subclinical hypothyroidism: Deciding when to treat. American Family Physician, 776 (February).Google Scholar
  2. Bernard. 1947. Principes de medicine expérimentale, Presses Universitaires de France: Paris, 391, cited in Canguilhem, Georges. 1991. The normal and the pathological (trans: Fawcett, C.). Zone Books: New York, 71.Google Scholar
  3. Bernard, Claude. 1957. An Introduction to the study of experimental medicine, trans, 63–65. New York: H. C. Greene, Dover. passim.Google Scholar
  4. Cholesterol Screening in Children. 1995. U. S. Public health service. American Family Physician, 1923. (June).Google Scholar
  5. Feinstein, A., et al. 1994. Variability in radiologists’ interpretations of mammograms. The New England journal of medicine 331: 1493.CrossRefGoogle Scholar
  6. Kannell, W., and R. Abbott. 1984. Incidence and prognosis of unrecognized myocardial infarction. The New England journal of medicine 311: 1144.CrossRefGoogle Scholar
  7. Kostis, J. 2008. Treating hypertension in the very old. New England Journal of Medicine (NEJM) 358: 1958.CrossRefGoogle Scholar
  8. Lipid Controversy Builds Up. 1992. Medical World News, 15. (October).Google Scholar
  9. Love, Susan. 1982. Fibrocystic ‘disease’ of the breast: A non-disease? The New England journal of medicine 307: 1010.CrossRefGoogle Scholar
  10. Love, Susan. 1997. Sometimes Mother Nature knows best. New York Times, 20. (March). reprinted in the Public Citizen Health Letter 13:1, 1997.Google Scholar
  11. Lown, Bernard. 2006. The commodification of health care. Hastings Center Report, p. 42. (September–October).Google Scholar
  12. Medical Tribune. 1992. 4 (April).Google Scholar
  13. Medical World News. 1988. 51. (August).Google Scholar
  14. Moskowitz, R. 1983. Vague, uncertain, long-term diagnosis: The Nocebo effect. Journal of the American Institute of Homeopathy (JAIH) 76: 26.Google Scholar
  15. Oliver, M. 1982. Risks of correcting the risks of coronary disease and strokes with drugs. The New England journal of medicine 306: 297.CrossRefGoogle Scholar
  16. Simon, H. 2002. Diagnosing prostate cancer: The PSA, 364. New York: The Harvard Medical School Guide to Men’s Health, Free Press.Google Scholar
  17. Spiro, H. 1985. Delayed diagnosis of disease. Journal of the AMA (JAMA) 253: 2258.CrossRefGoogle Scholar
  18. Thompson, I., et al. 2004. Prevalence of prostate cancer among men with a PSA level at or below 4.0 ng. Per Milliliter. The New England journal of medicine 350: 2239.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.WatertownUSA
  2. 2.Jamaica PlainUSA

Personalised recommendations